author-photo

Paul Fishkin

Mayo Clinic

21

Papers

635

Citations

Citation Trend

Filter By

Papers (15) Sort By

Journal Conference Others

Clinical Careers in Hematology (Private Practice Careers)

2019
- Paul Fishkin
Show All
- Source
- Cite
- Save
Citations (0)
Evaluation of chemotherapy within last two weeks of life: Patterns of care.

2017 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Dynamic Contrast-Enhanced Magnetic Resonance Imaging as a Pharmacodynamic Biomarker for Pazopanib in Metastatic Renal Carcinoma

2017 Clinical Genitourinary Cancer
Show All
- Source
- Cite
- Save
Citations (9)
A prospective international randomized phase II study evaluating the food effect on the pharmacokinetics (PK) and pharmacodynamics (PD) of abiraterone acetate (AA) in men with castration-resistant prostate cancer (CRPC).

2017 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (6)
Phase II study of rituximab and cladribine (2-CDA) in newly diagnosed mantle cell lymphoma (MCL) (N0189)

2016 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (2)
Concurrent EGFR Mutation and ALK Translocation in Non-Small Cell Lung Cancer.

2016 Cureus
Show All
- Source
- Cite
- Save
Citations (15)
Phase I trial of rituximab, cladribine, and temsirolimus (RCT) for initial therapy of mantle cell lymphoma

2014 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (15)
Phase I Trial of Rituximab, Cladribine and Temsirolimus (RCT) for Initial Therapy of Mantle Cell Lymphoma

2012 Blood
Show All
- Source
- Cite
- Save
Citations (2)
Tetracycline to prevent epidermal growth factor receptor inhibitor-induced skin rashes: Results of a placebo-controlled trial from the North Central Cancer Treatment Group (N03CB)

2008 Cancer
Show All
- Source
- Cite
- Save
Citations (160)
Long‐term results of the treatment of patients with mantle cell lymphoma with cladribine (2‐CDA) alone (95‐80‐53) or 2‐CDA and rituximab (N0189) in the North Central Cancer Treatment Group

2008 Cancer
Show All
- Source
- Cite
- Save
Citations (60)